Ways to reach us:
US Headquarters – Phone: 201-684-8000
750 Corporate Drive
Mahwah, NJ 07430
US Manufacturing – Phone: 704-218-2621
4147 Goldmine Road
Monroe, NC 28110
Glenmark Pharmaceuticals Canada, Inc.
1600 Steeles Ave West, Suite 407
Phone: (905) 660-7797
Fax: (905) 660-7717
Public policy and healthcare decisions made by lawmakers at all levels of government are critical to encouraging research and development of new innovative therapies while also ensuring that patients have access to the medications they need to lead healthy and productive lives. At Glenmark, patient care is our number one priority and serves as the driving force behind our mission to continue to produce critical medicines while investing in the therapies of tomorrow. In alignment with our mission, Glenmark is actively engaged in local, state, federal and global public policy discussions on the most critical issues impacting healthcare. To reach our government affairs office, please contact:
Grant Erdel, Vice President of Government Affairs, Grant.Erdel@glenmarkpharma.com
US Medical Information, Pharmacovigilance, and Quality Assurance:
To receive medical or safety information or to report a product complaint or side effect (also called an adverse event), please contact the Glenmark customer service center at:
GlobalCustomerService@glenmarkpharma.com or at 1-888-721-7115. Hours: 9:00 a.m. – 6:00 p.m., EST.
The FDA has established a reporting service known as MedWatch, to which healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs they prescribe, dispense or use. Visit MedWatch or call 1-800-FDA-1088. Additional information on how to report problems with medication, including a convenient, downloadable consumer guide, is available on the FDA website by clicking here.